Thrombospondin-2 is a Highly Specific Diagnostic Marker and is Associated with Prognosis in Pancreatic Cancer

Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States

Lola Rahib, Benjamin D. Smith, Rhonda Aizenberg et al. · Cancer Research · 2014 · 7.3K citations

Medicine, Oncology, Cancer Epidemiology +16

ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer

Gershon Y. Locker, Stanley R. Hamilton, Jules E. Harris et al. · Journal of Clinical Oncology · 2006 · 1.6K citations

Medicine, Oncology, Surgery +8

Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis

Julia Mayerle, Holger Kalthoff, Regina Reszka et al. · Gut · 2017 · 337 citations · Full text

Medicine, Biochemistry, Oncology +17

Thrombospondins 1 and 2 are Necessary for Synaptic Plasticity and Functional Recovery after Stroke

Jason Liauw, Stanley Hoang, Michael Y. Choi et al. · Journal of Cerebral Blood Flow & Metabolism · 2008 · 268 citations · Full text

Medicine, Neurology, Neuroscience +17

Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers

Jung-Sun Kim, William R. Bamlet, Ann L. Oberg et al. · Science Translational Medicine · 2017 · 263 citations · Full text

Medicine, Oncology, Pathology +13